Chapter 10

Clinical Applications of Artificial Intelligence in Early and Accurate Detection of Low-Concentration CVD Biomarkers

First published: 22 April 2022

Abstract

Cardiovascular diseases (CVDs) are a mix of several types of disorders affecting the heart and blood vessels. A biosensor is considered as a very effective analytical tool in medical diagnostics for rapid detection of CVD disease at an early stage. CVD diagnostic techniques require blood tests to assess relevant biomarker levels. This chapter discusses that there are various types of biosensor: optical biosensors, electrochemical biosensors, and magnetic biosensors. Artificial intelligence (AI) provides excellent tools for the discovery of new biosensing materials for the early and precise detection of CVDs. The chapter describes some of the AI techniques used in cardiovascular medicine and digital healthcare applications. Technological advancements in AI have opened new areas and tools in the creation of novel modeling and predictive techniques for clinical applications in CVDs and have begun to infuse and reform cardiovascular medicine.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.